In this work, an attempt was made to induceng resistance to 3 schistosomi¬ cidal drugs in a Brazilian strain of S. mansoni, according to the Type II resistance induction scheme proposed by JANSMA et al. in 1977. Three attempts were unsuccessful.
INTRODUCTION
In Brazil, Schistosomiasis mansoni is an important endemic disease, in several States 9 , affecting about 10% of the Brazilian population. Many control program have been implemented, mostly employing chemotherapy as one of the main prophylactic methods to fight this parasitosis.
Mass treatment is currently being undertaken in Brazil using oxamniquine, with relative success, since the susceptibility of the Brazilian strains of S. mansoni to chemotherapeutic agents is reasonably good. Nevertheless several human strains resistant to oxamniquine have been described in Brazil 2,3,4,53. Fortunately, the resistance phenomenon so far seems not to be an^pidemiological problem since the cases of resistant worms are not numerous and, whenever tested, these strains showed susceptibility to praziquantel 1 ,*. It is easy to foresee, however, the negative repercussions of a strain of S. mansoni resistant to oxamniquine and/or other chemotherapeutic agent which might spread out in a given region.
Research on the mechanism of resistance development started with Rogers and Bueding, who, using mice infected in the laboratory, succeeded in experimentally induce resistance to hycanthone and oxamniquine in the progeny of worms treated with subtherapeutical doses of hycanthone 13 .
JANSMA et al. 7 induced resistance to hycanthone and oxamniquine in the progeny of worms experimentally manipulated (further resistance) in 3 out of 5 strains of S. mansoni via three induction schemes. Type I resistance was obtained by means similar to those used by ROGERS & BUEDING 13 . Type II resistance was induced by treating mice harbouring the parental worm generation with subtherapeutic dosages of the drug at the time of the immature stage of infection, during the embriological development of the reproductive system. Type III resistance was produced by infection of mice with cercariae of only one sex, followed by infection with cercarie of the opposite sex 2 to 58 weeks later, which didn't have any contact with the drug. The three types of resistance were limited to the progeny of the parental worms which showed susceptibility to the drugs used.
Theoretically, all these methods for producing resistance to S. mansoni could be inadvertently reproduced in the field, where mass treatment is frequently carried out indiscriminately. We believe that an experimental study on the resistance development possibility of in human strains of S. mansoni to certain drugs is very important, specially for determining the chemotherapeutic agent of choice for mass treatment of a population.
MATERIALS AND METHODS

S. mansoni strain
A Brazilian strain of S. mansoni, kept in our laboratory for several years, was used. It •was isolated from a patient infected in Belo Horizonte, Minas Gerais, Brazil, and was named BH strain. In previous studies, this strain has already shown susceptibility to oxamniquine, praziquantel, niridazole and nyanthone 4 .
S. mansoni hosts
Female albine mice (Mus musculus) weighing approximately 15 g at infection were used as definitive host.
Intermediate hosts were laboratory raised albine Biomphalaria glabrata, descendant from molluscs captured in Belo Horizonte, Minas Gerais, Brazil. The faeces of the animals in the control subgroup were used to obtain miracidia of F t generation, 'which were used for mass infection of B. glabrata 14 . The control subgroup was also used as standard for measuring the susceptibility of the trial subgroup.
After elimination of the cercariae from B. glabrata infected with F, generation, new groups of mice were inoculated through the tail with 70 cercariae.
Sixty days after the cercarian infection, the 3 groups of F, mice were divided into 2 subgroups: trial and control. The mice in the trial subgroup were treated with therapeutic dosages of the respective drug. Twenty days after the treatment, the animals in both subgroups were killed, and perfusion and oograms of the small intestine were performed 12 -is.
A similar scheme was applied to F, gene ration. 
RESULTS
The percentage of males (Table I) was established in order to safely use the criterion of "worm distribution", because in the case of poorly balanced inoculations, with predominance of one sex, there is a tendency towards the concentración of the worms in the liver and porta vein ^,17.
in this way, the data of the concentration of the worms in the liver since there was a tendency in the trial subgroup to present a higher percentage of males. After treatment it was more difficult to find female than male worms due to their small size, desintegraron and encapsulation in liver granulomas.
In 3 generations the mean, percentage of males in all control subgroups was 58.1% with a standard deviation of 9.7%, varying from 44.9% to 71.6% and thus compatible with the use of the "worm distribution" criterion for susceptibility analysis.
Results were very similar in all therapeutic groups. The parenteral generation of the worm was susceptible to the 3 drugs used (Table I ). All trial subgroups presented large percentages of worms in the liver and porta vein, significant reduction of parasite load compared to the control subgroup, high rates of worm reduction, low rates of surviving worms and 100% change in oograms. These results occurred both in the parental generation and in ¥ l (Table I) , suggesting susceptibility of both generations, and therefore, failure of the attempt to induce resistance. Analysis of the P 2 generation showed results nearly identical to F,.
An interesting and unexpected finding in the experiment was that the parental generation showed lower susceptibility than ^ and P 2 generations, since in the former some surviving worms were still found after treatment, while in P t and P 2 surviving worms were practically inexistent.
DISCUSSION
The results showed that when submitted to JANSMA et al. Type II resistance induction scheme with the 3 schistosomicidal drugs used, contrary to expected, the susceptbiility of S. mansoni strain increased in successive worm generations. This not only indicated failure in the attempt to induce resistance but also broadened the possibilities for production of resistance to schistosomicides in S. mansoni strains.
Many explanations can be offered for the fact that the parental generation present lower susceptibility than its progeny. The fact that the only difference in the manipula tion of parental and progeny generations was the treatment of the parental generation dur ing the immature stage of infection, lead us to raise the hypothesis that this treatment may have lowered the susceptibility of the parental generation, perhaps through an enzymatic induction process. This observation may be of value and opens new fields of research on the mechanism of producing resistance to schistosomicidal agents in S. mansoni. Furthermore, failure in the attempt to induce resistance to schistosomicides in a Brazilian strain of S. mansoni is a good result, because it suggests a low potential of this strain to become resistant, in a country where mass treatment situations favour the development of such a resistance. Nevertheless more trials must be undertaken to evaluate this potential in relation to other brazilian strains, applying different induction schemes. 
